ROYCE & ASSOCIATES LP - ANTARES PHARMA INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2016$684,000
+60.2%
406,9000.0%0.01%
+66.7%
Q2 2016$427,000
+20.6%
406,9000.0%0.00%
+50.0%
Q1 2016$354,000
+200.0%
406,900
+318.3%
0.00%
+100.0%
Q4 2015$118,00097,2840.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,598,329$10,852,0004.99%
Soleus Capital Management, L.P. 864,100$2,039,0002.37%
Healthcare Value Capital, LLC 500,000$1,180,0001.98%
ORACLE INVESTMENT MANAGEMENT INC 1,227,114$2,896,0000.86%
PERKINS CAPITAL MANAGEMENT INC 232,166$548,0000.66%
Stonepine Capital Management, LLC 151,189$357,0000.38%
Zebra Capital Management LLC 84,963$200,0000.32%
Intrinsic Edge Capital Management LLC 1,000,000$2,360,0000.31%
Alambic Investment Management, L.P. 46,069$109,0000.26%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$473,0000.26%
View complete list of ANTARES PHARMA INC shareholders